When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Electromed (ELMD) is a profitable medical device company in a small but growing market niche. The company has historically experienced uneven bottom line growth as it is dependent on one-time sales of its main product. Activist funds have taken large positions believing the stock to be undervalued. Management has restructured its sales team as it attempts to gain market penetration. The restructuring will provide immediate cost savings and potentially improve the company's earnings. The company is also an attractive acquisition target as it has been consistently profitable and cash flow positive.